TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.45$ +0.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 165 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VXRT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
106 92 89 114 167 166 159 164 209 186 180 165
57 46 44 72 66 68 63 70 117 136 132 117
33 35 27 43 22 25 29 20 17 54 51 51
53 40 37 63 59 52 42 26 29 64 61 64
0.4 3.0 2.3 4.8 3.7 12 16 41 86 51 58 47
0.8 0.0 0.0 – -4.1 – – – – – – –
4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
4.5 4.3 4.1 3.9 3.7 3.6 3.4 3.2 3.0 2.8 2.6 2.5
34 34 33 34 98 107 113 131 182 98 86 83
11 14 14 16 80 91 99 118 169 87 77 73
3.9 6.5 5.2 5.6 5.6 7.1 3.3 3.5 3.8 3.0 2.5 2.5
1.3 1.6 4.0 3.6 2.5 7.0 17 11 53 21 24 17
72 58 56 80 68 59 46 33 27 88 94 82
-392 -410 -434 -450 -465 -477 -492 -507 -515 -460 -455 -469
177 177 177 177 177 228 228 228 229 230 242 242

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?